FrontNationNewsTop StoriesWorld
Trending

Donald Trump applauds India for lifting ban on sale of Hydroxycloroquine drug

Hydroxychloroquine, a key anti-malaria drug, is being used as a mechanism to stem the spread of novel coronavirus. This unproven drug became Donald Trump’s miraculous aide as the number of the coronavirus cases in the United States of America surged to 400,000, with death toll rising over 12,000. India lifted its curbs upon certain drug exports including the Hydroxychloroquine drug renowned to be the experimental medicine to treat the coronavirus pandemic. India initiated relaxations on the ban after US president threatened possible retaliation against India if New Delhi failed to export the Hydroxychloroquine medicine to the US.

Considering India’s mutually beneficial relations with the United States the reversal of the export ban came to decision after US President Donald Trump urged Prime Minister Narendra Modi in a telephonic conversation to comply with his request on export of the anti-malarial medicine since India is the major producer of the Hydroxychloroquine drug.

According to the US Food and Drug Administration, hydroxychloroquine has been identified as a possible medicine for the treatment of the Coronavirus. They further stated that the drug has been tested on more than 1500 coronavirus patients in the New York City.

Donald Trump confirmed that he has purchased over 29 million doses of the drug, he went on to shower praises to India and lauded PM Narendra Modi’s move to lift the ban and extend support to the United States in a time mounting coronavirus pandemic.

– Christo Freddy, NMTV News

Tags

NMTV

NMTV was launched in the year 1999, and is Maharashtra only accredited 24-hour, 7-day-a-week local cable news station of Navi Mumbai airing news bulletins and programs in English, Hindi and Marathi. NMTV represents the state-of-the-art in local television news coverage, delivering on a commitment of responsible and community-oriented journalism on an around-the-clock basis.

Related Articles

Back to top button
Close
Close